CYTOSORBENTS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
CYTOSORBENTS CORPORATION (CTSO) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $0.64 per share as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2026-03-30
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.64.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $0.93.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.28.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price as first filed |
|---|---|---|
| 2025-12-31 | $0.64 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.93 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.28 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.00 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $0.91 10-K · filed 2025-03-31 | |
| 2024-09-30 | $1.50 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.70 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $0.95 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.11 10-K · filed 2024-03-15 | |
| 2023-09-30 | $1.88 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.59 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $3.37 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $1.55 10-K · filed 2023-03-09 | |
| 2022-09-30 | $1.36 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.19 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $3.19 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $4.19 10-K · filed 2022-03-10 | |
| 2021-09-30 | $8.12 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $7.55 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $8.68 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $7.97 10-K · filed 2021-03-09 | |
| 2020-09-30 | $7.97 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $9.90 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $7.73 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $3.85 10-K · filed 2020-03-05 | |
| 2019-09-30 | $5.03 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $6.61 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $7.57 10-Q · filed 2019-05-07 | |
| 2018-09-30 | $12.90 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $11.40 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $7.05 10-Q · filed 2018-05-08 | |
| 2017-06-30 | $4.30 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $4.50 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $7.81 10-K · filed 2017-03-03 | |
| 2016-09-30 | $7.81 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $7.81 10-Q · filed 2017-08-07 | |
| 2016-03-31 | $7.81 10-Q · filed 2017-05-08 | |
| 2015-12-31 | $7.81 10-K · filed 2017-03-03 | |
| 2015-09-30 | $7.81 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $7.81 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $7.81 10-Q · filed 2016-05-09 | |
| 2014-12-31 | $7.81 10-K · filed 2017-03-03 | |
| 2014-09-30 | $0.31 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $0.31 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $0.31 10-Q · filed 2014-05-14 | |
| 2014-03-11 | $7.81 10-K · filed 2015-03-31 | $0.31 10-Q · filed 2014-05-14 |
| 2014-03-07 | $7.81 10-K · filed 2016-03-09 | $0.31 10-Q · filed 2014-05-14 |
| 2012-09-30 | $0.10 10-Q · filed 2012-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |